A group of independent advisors to the US Food and Drug Administration — including infectious disease, vaccine, and biostatistics experts — are meeting this week to establish guidelines for how they will make recommendations regarding the use of SARS-CoV-2 vaccines, the Washington Post reports. It notes that the FDA typically follows the recommendations of its advisory committees.